99+ Total results for product and free and sample content found
Scrip: 世界の医療用医薬品&製薬産業に関するニュース
For Scrip’s annual preview our journalists asked over 200 industry executives and experts for their predictions of the major trends for 2021. From the pandemic, to AI, therapeutics, and the new US leadership, here’s what to watch out for – in a year with so much at stake.
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
The COVID-19 pandemic is disrupting global supply chains and companies need effective tools to manage the related contract disputes. Sidley Austin partner Dorothee Schramm and senior associate Katie von der Weid, both specialized in international commercial disputes, provide tips to help companies manage the situation.
HBW Insight : コンシューマーヘルスケア産業のニュース
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
Topic business-strategies Cosmetics
Medtech Insight: 世界の医療機器・医療技術の最新情報
An expert panel at CES 2020 discussed Deloitte's vision for health care in 2040, with the empowered consumer managing their own health, enabled by a new ecosystem of secure, open access to data and "nudges" to change behaviors. Consulting firm Deloitte foresees outside disruptors dismantling the traditional health-care system, but panelists from Johnson & Johnson and Anthem flexed their muscles.
In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース
Bayer’s ambitious campaign to reposition itself as a global leader in two complementary fields – health and nutrition – will face its toughest test in the US, with its highly litigious approach to product liability and a tendency to target pharmaceuticals as the source of the health system’s affordability and access problems.
HBW Insight : コンシューマーヘルスケア産業のニュース
Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions.
Scrip: 世界の医療用医薬品&製薬産業に関するニュース
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
Scrip: 世界の医療用医薬品&製薬産業に関するニュース
In a year epitomized by a global pandemic, the depth and implications of pharma activity across Asia has been staggering. Gain unique insight into the companies, products and themes leading the industry when you download the Scrip Asia 100 Report, written by our experienced on-the-ground journalists throughout this vast region.
Topic business-strategies
No Records Found
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
*一部のサービスでは無料トライアルをご利用になれません。
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。
インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com
*Omdia(ICT産業の情報)に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。